adjuvant news from FierceVaccines
News
Iomai gets boost in bird flu vaccine adjuvant study
In a Phase I/II trial, three out of every four people in a study of 500 people using an adjuvant patch developed by Iomai achieved a protective immune response after a single dose. That compares to Read more...
Get more adjuvant coverage at:
Paid Research Reports
- Pipeline Insight: Nosocomial Vaccines - Minefield or Goldmine?
- Drug Approval Trends at the FDA and EMEA: Process improvements, heightened scrutiny and industry response
- Biotech 2008 – life sciences industry report (online & print)
- Is there a market for alcoholism pharmacotherapies?
- New report provides Rheumatoid Arthritis market insight